Business Intelligence and Advanced Metrics Tracking technology deployed across PMG clinical trial site network
Charleston, SC - PMG Research, Inc. and Devana Solutions, LLC, today announced a long-term subscription agreement for the use of Devana's advanced cloud-based technology across PMG's industry-leading network of over 50 investigative site locations.
The agreement allows PMG's integrated network of sites to adopt Devana's Ignite for Sites platform to fully automate its operations from study lead through trial completion.
In addition to PMG's more than 7,700 completed clinical trials, the advanced Devana Solutions technology simultaneously tracks, aggregates and allows PMG to display and report its timing and performance metrics in real-time for all trials currently running across its entire site network.
This technology advantage, coupled with best-in-class trial management capabilities, will allow PMG Research to expand its industry leading position and secure additional trials in partnership with pharmaceutical sponsors and CROs.
Amanda Wright, Senior Director of Client Services and Communications at PMG, commented: "PMG Research has always embraced technology innovation as an important way to grow our business and to fulfill the organization's mission of bringing clinical research to as many people as possible.
"Devana Solutions system allows for the end-to-end capture of data that will us to continue to demonstrate to CROs and Sponsors that our performance is among the best in the industry and that PMG is committed to the highest standards."
Barry Lake, CEO & Executive Chairman of Devana, added: "PMG is clearly a leader in the site operations enterprise and we are thrilled to partner with them.
"From the first conversation, they shared Devana Solutions' opinion that more and better data about site performance will mean that the most capable networks of sites, like PMG Research, will win more awards, leading to shorter cycle times for trials, lower costs and, ultimately, lower cost treatments for patients."
About PMG ResearchPMG Research, Inc. is an integrated network of clinical research facilities with fourteen hub sites located in Champaign, IL; Ames, IA; Cary, Charlotte, Hickory, Raleigh, Rocky Mount, Salisbury, Statesville, Wilmington, and Winston-Salem, NC; Charleston, SC; and Bristol and Knoxville, TN. PMG has conducted over 7,700 research studies for hundreds of pharmaceutical sponsors and CROs since 1979. We have extensive experience conducting all phases of trials across a comprehensive list of conditions. Our mission is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to our clinical trial partners and stakeholders.
About Devana SolutionsDevana Solutions is driven by a core belief that selection of top-performing Research Sites to align with drug sponsors and CROs is key to reducing drug costs and curing disease. Its IGNITE FOR SITES cloud-based platform centralizes study leads and contacts and automates pipeline administration while proprietary algorithms simultaneously track the site's timing and performance metrics from study lead through trial completion. With a couple of mouse clicks, these metrics can be standardized into reports for drug sponsors and CROs to validate the site's capabilities. Its MATCH PERFORMANCE reduces site selection risk for CRO's and sponsors by providing access to historical and real-time performance & timing metrics on investigator sites, improving trial feasibility and performance while reducing clinical trial cycle time and costs.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.